# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-22-026271
Filing Date
2022-10-12
Accepted
2022-10-11 21:16:36
Documents
17
Period of Report
2022-10-12
Items
Item 8.01: Other Events

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | sgmo-20221012.htm iXBRL | 8-K | 61611
5 | GRAPHIC | sgmo-20221012_g1.jpg | GRAPHIC | 1021013
6 | GRAPHIC | sgmo-20221012_g2.jpg | GRAPHIC | 350603
7 | GRAPHIC | sgmo-20221012_g3.jpg | GRAPHIC | 407346
8 | GRAPHIC | sgmo-20221012_g4.jpg | GRAPHIC | 536005
9 | GRAPHIC | sgmo-20221012_g5.jpg | GRAPHIC | 466000
| Complete submission text file | 0001628280-22-026271.txt |  | 6780639

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sgmo-20221012.xsd | EX-101.SCH | 1941
3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sgmo-20221012_lab.xml | EX-101.LAB | 24132
4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sgmo-20221012_pre.xml | EX-101.PRE | 12545
11 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmo-20221012_htm.xml | XML | 11309

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 221305442
SIC: 2836 Biological Products, (No Diagnostic Substances)